FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

Publication | Open Access

DOI Full Paper Access

399

Citations

References

2006

Year

John Souglakos, N. Androulakis, K. Syrigos, Aris Polyzos, Nikolaos Ziras, A. Athanasiadis, Stylianos Kakolyris, S. Tsousis, Ch. Kouroussis, L. Vamvakas,

British Journal of Cancer